Chromosome 17p-linked prostrate cancer susceptibility gene and a paralog and orthologous genes

Abstract

The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect a human prostate cancer predisposing gene (HPC2), some alleles of which cause susceptibility to cancer, in particular prostate cancer. More specifically, the present invention relates to germline mutations in the HPC2 gene and their use in the diagnosis of predisposition to prostate cancer. The invention also relates to presymptomatic therapy of individuals who carry deleterious alleles of the HPC2 gene. The invention further relates to somatic mutations in the HPC2 gene in human prostate cancer and their use in the diagnosis and prognosis of human prostate cancer. Additionally, the invention relates to somatic mutations in the HPC2 gene in other human cancers and their use in the diagnosis and prognosis of human cancers. The invention also relates to the therapy of human cancers which have a mutation in the HPC2 gene, (including gene therapy, protein replacement therapy, protein mimetics, and inhibitors). The invention further relates to the screening of drugs for cancer therapy. The invention also relates to the screening of the HPC2 gene for mutations, which are useful for diagnosing the predisposition to prostate cancer. In addition, the invention relates to a paralog of human HPC2, the paralog being named ELAC1, and to orthologs of human HPC2, these being mouse Elac2, chimpanzee Elac2 and gorilla Elac2.

What is claimed is:  
     
         1 . A kit comprising primers for sequencing the region of HPC2 encoding i) amino acid residue 217 or ii) amino acid residue 541.  
     
     
         2 . A kit comprising i) primers for sequencing the region of HPC2 encoding amino acid residue 217 and ii) primers for sequencing the region of HPC2 encoding amino acid residue 541.  
     
     
         3 . A kit comprising primers for performing an allele specific polymerase chain reaction wherein one primer is complementary to a region of HPC2 comprising the codon encoding i) amino acid residue 217 or ii) amino acid residue 541.